What's Going On With Tonix Pharmaceuticals Stock Today?
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Tuesday after initially jumping after the company ...
Tonix Pharmaceuticals Gets FDA Review of Fibromyalgia Drug
Tonix Pharmaceuticals Holding said the Food and Drug Administration has accepted its application seeking approval of its TNX-102 SL product candidate for the chronic pain condition fibromyalgia.
Tonix Pharma’s TNX-102 SL Nears FDA Approval Milestone
Tonix Pharma ( (TNXP) ) has provided an announcement.
kalkinemedia21h
FDA accepts Tonix’s NDA for non-opioid fibromyalgia drug TNX-102 SL
(Nasdaq: TNXP) announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for ...
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Shares of Corvus Pharmaceuticals, Inc. CRVS +18.3% + Free Alerts rose sharply in today's pre-market trading after the company ...
The Globe and Mail17h
This Micro Cap Is Getting Bid Up Prior To Opening Bell
Traders were quick to snatch up shares of Tonix Pharmaceuticals Holding Corp. (Nassdaq:TNXP) following the announcement, with ...
Monthly Prescribing Reference18h
FDA to Review Sublingual Cyclobenzaprine for Fibromyalgia Management
The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.
Yahoo Finance15h
Tonix Pharmaceuticals Holding Corp. (TNXP)
Trailing total returns as of 12/11/2024, which may include dividends or other distributions. Benchmark is S&P 500 ...
Bloomberg L.P.17h
Tonix Pharmaceuticals Holding Corp
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Morningstar58m
The Fed was more lucky than right in the fight against inflation - and still getting it wrong, these researchers say.
Happy Fed day to all who observe. Not everyone celebrates. There is of course the debate for this decision, whether the data really supports the interest rate cut that basically everybody seems to ...
Morningstar1h
The Fed was more lucky than right in the fight against inflation, these researchers say.
Happy Fed day to all who observe. Not everyone celebrates. There is of course the debate for this decision, whether the data really supports the interest rate cut that basically everybody seems to ...
Yahoo Finance14h
Rhythm Pharmaceuticals, Inc. (RYTM)
JMP Securities raised the firm’s price target on Rhythm Pharmaceuticals (RYTM) to $75 from $64 and keeps an Outperform rating on the shares as part of a broader note on Biotechnology.